Bowelia Burgorferi Detected by Culture and PCR in Clinical Relapse of Disseminated Lyme Borreliosis

References

• Preac-Mursic V, Weber K, Pfister H W, Wilske B, Gross B, Baumann A, et al. Survival of Borrelia burgdorferi in antibiotically treated patients with Lyme borreliosis. Infection 1989; 17: 355–9
   PubMed Web of Science ®Google Scholar
• Hassler D, Riedel K, Zorn J, Preac-Mursic V. Pulsed high-dose cefotaxime therapy in refractory Lyme borreliosis (letter). Lancet 1991; 338: 193
   Google Scholar
• Viljanen M K, Oksi J, Salomaa P, Skurnik M, Peltonen R, Kalimo H. Cultivation of Borrelia burgdorferi from the blood and a subcutaneous lesion of a patient with relapsing febrile nodular nonsuppurative panniculitis (letter). J Infect Dis 1992; 165: 596–7
   Google Scholar
• Liegner K B, Rosenkilde C E, Campbell G L, Quan T J, Dennis D T. Culture-confirmed treatment failure of cefotaxime and minocycline in a case of Lyme meningoencephalomyelitis in the United States. Program and Abstracts of the 5th International Conference on Lyme borreliosis. May 30-June 2, 1992. Arlington, VAUSA, A10
   Google Scholar
• Bradley J F, Johnson R C, Goodman J L. The persistence of spirochetal nucleic acids in active Lyme arthritis. Ann Intern Med 1994; 120: 487–9
   PubMed Web of Science ®Google Scholar
• Kantor F S. Disarming Lyme disease. Sci Am 1994; 271: 34–9
   Google Scholar
• Maiwald M, Stockinger C, Hassler D, Doeberitz M VK, Sonntag H G. Evaluation of the detection of Borrelia burgdorferi DNA in urine samples by polymerase chain reaction. Infection 1995; 23: 173–9
   PubMed Web of Science ®Google Scholar
• Sigal L H. Management of Lyme disease refractory to antibiotic therapy. Rheum Dis Clin North Am 1995; 21: 217–30
   Google Scholar
• Halperin J, Keller T, Whitman M. PCR-based detection of CSF Borrelia burgdorferi as a predictor of treatment response in CNS Lyme borreliosis. Lyme Borreliosis, J S Axford, D HE Rees. Plenum Press, New York 1994; 295–301
   Google Scholar
• Steere A C. Musculoskeletal manifestations of Lyme disease. Am J Med 1995; 98: 44S–8
   Google Scholar
• Ziska M, Demarest F, Donta S T. Physicians preferences in the diagnosis and treatment of Lyme disease in the United States. Infection 1996; 24: 182–6
   PubMedGoogle Scholar
• Centers for Disease Control. Case definitions for public health surveillance/Lyme disease. MMWR. Morbid Mortal Wkly Rep 1990; 39: 19–21
   Google Scholar
• Rahn D W, Malawista S E. Lyme disease: recommendations for diagnosis and treatment. Ann Intern Med 1991; 114: 472–81
   PubMed Web of Science ®Google Scholar
• Viljanen M K, Punnonen J. The effect of storage of antigen-coated polystyrene microwells on the detection of antibodies against Borrelia burgdorferi by enzyme immunoassay (EIA). J Immunol Methods 1989; 124: 137–41
   PubMed Web of Science ®Google Scholar
• Hance A J, Grandchamp B, Lévy-Frébault V, Lecossier D, Rauzier J, Bocart D, et al. Detection and identification of mycobacteria by amplification of mycobacterial DNA. Mol Microbiol 1989; 3: 843–9
   PubMedGoogle Scholar
• Wallich R, Moter S E, Simon M M, Ebnet K, Heiberger A, Kramer M D. The Borrelia burgdorferi flagellum-associated 41-kilodalton antigen (flagellin): molecular cloning, expression, and amplification of the gene. Infect Immun 1990; 58: 1711–9
   Google Scholar
• Krüger W H, Pulz M. Detection of Borrelia burgdorferi in cerebrospinal fluid by the polymerase chain reaction. J Med Microbiol 1991; 35: 98–102
   PubMed Web of Science ®Google Scholar
• Picken R N. Polymerase chain reaction primers and probes derived from flagellin gene sequences for specific detection of the agents of Lyme disease and North American relapsing fever. J Clin Microbiol 1992; 30: 99–114
   PubMed Web of Science ®Google Scholar
• He Q S, Marjamäki M, Soini H, Mertsola J, Viljanen M K. Primers are decisive for sensitivity of PCR. Biotechniques 1994; 17: 82–5
   PubMed Web of Science ®Google Scholar
• Kekomäki R, Penttinen K. Platelets and 125I-labelled staphylococcal protein A in the detection of immune complexes in serum. J Clin Lab Immunol 1979; 1: 542–4
   Google Scholar
• Oksi J, Kalimo H, Marttila R J, Marjamäki M, Sonninen P, Nikoskelainen J, et al. Inflammatory brain changes in Lyme borreliosis. A report on three patients and review of literature. Brain 1996; 119: 2143–54
   PubMed Web of Science ®Google Scholar
• Oksi J, Nikoskelainen J, Viljanen M K. Comparison of oral cefixime and intravenous ceftriaxone followed by oral amoxicillin in disseminated Lyme borreliosis. Eur J Clin Microbiol Infect Dis 1998; 17: 715–9
   PubMed Web of Science ®Google Scholar
• Dattwyler R J, Halperin J J, Volkman D J, Luft B J. Treatment of late Lyme borreliosis - randomised comparison of ceftriaxone and penicillin. Lancet 1988; 1: 1191–4
   PubMed Web of Science ®Google Scholar
• Karlsson M, Hammers-Berggren S, Lindqutst L, Stiernstedt G, Svenungsson B. Comparison of intravenous penicillin G and oral doxycycline for treatment of Lyme neuroborreliosis. Neurology 1994; 44: 1203–7
   PubMed Web of Science ®Google Scholar
• Dattwyler R J, Luft B J, Kunkel M J, Finkel M F, Wormser G P, Rush T J, et al. Ceftriaxone compared with doxycycline for treatment of acute disseminated Lyme disease. N Engl J Med 1997; 337: 289–94
   PubMed Web of Science ®Google Scholar
• Donta S T. Tetracycline therapy for chronic Lyme disease. Clin Infect Dis 1997; 25(Suppl 1)S52–56
   PubMed Web of Science ®Google Scholar
• Junttila J, Peltomaa M, Soini H, Marjamäki M, Viljanen K. Prevalence of Borrelia burgdorferi in Ixodes ricinus ticks in urban recreational areas of Helsinki. J Clin Microbiol 1999; 37: 1361–5
   PubMed Web of Science ®Google Scholar
• Pal G S, Baker J T, Wright D J. Penicillin-resistant Borrelia encephalitis responding to cefotaxime (letter). Lancet 1988; 1: 50–1
   Google Scholar
• Hassler D, Maiwald M. Re-infection with Borrelia burgdorferi in an immunocompetent patient. Dtsch Med Wochenschr 1994; 119: 338–42
   PubMedGoogle Scholar
• Liegner K B, Shapiro J R, Ramsay D, Halperin A J, Hogrefe W, Kong L. Recurrent erythema migrans despite extended antibiotic treatment with minocycline in a patient with persisting Borrelia burgdorferi infection. J Am Acad Dermatol 1993; 28: 312–4
   PubMed Web of Science ®Google Scholar
• Montgomery R R, Nathanson M H, Malawista S E. The fate of Borrelia burgdorferi, the agent for Lyme disease, in mouse macrophages. Destruction, survival, recovery. J Immunol 1993; 150: 909–15
   PubMed Web of Science ®Google Scholar
• Klempner M S, Noring R, Rogers R A. Invasion of human skin fibroblasts by the Lyme disease spirochete, Borrelia burgdorferi. J Infect Dis 1993; 167: 1074–81
   PubMed Web of Science ®Google Scholar
• Georgilis K, Peacocke M, Klempner M S. Fibroblasts protect the Lyme disease spirochete, Borrelia burgdorferi, from ceftriaxone in vitro. J Infect Dis 1992; 166: 440–4
   PubMed Web of Science ®Google Scholar
• Ma Y, Sturrock A, Weis J J. Intracellular localization of Borrelia burgdorferi within human endothelial cells. Infect Immun 1991; 59: 671–8
   PubMed Web of Science ®Google Scholar
• Oksi J, Uksila J, Marjamäki M, Nikoskelainen J, Viljanen M K. Antibodies against whole sonicated Borrelia burgdorferi spirochetes, 41-kilodalton flagellin, and P39 protein in patients with PCR- or culture-proven late Lyme borreliosis. J Clin Microbiol 1995; 33: 2260–4
   PubMed Web of Science ®Google Scholar
• Schutzer S E, Coyle P K, Belman A L, Golightly M G, Drulie J. Sequestration of antibody to Borrelia burgdorferi in immune complexes in seronegative Lyme disease. Lancet 1990; 335: 312–5
   PubMed Web of Science ®Google Scholar
• Reijonen H, Ilonen J, Knip M, Reunala T. Insulin-dependent diabetes mellitus associated with dermatitis herpetiformis: evidence for heterogeneity of HLA-associated genes. Tissue antigens 1991; 37: 94–6
   Google Scholar
• Steere A C, Dwyer E, Winchester R. Association of chronic Lyme arthritis with HLA- DR4 and HLA-DR2 alleles. N. Engl J Med 1990; 323: 219–23
   PubMed Web of Science ®Google Scholar
• Oksi J. Lyme borreliosis (letter). Lancet 1995; 345: 1437
   Google Scholar